Xiaohong Shen

Xiaohong Shen serves as the Director of Pharmaceutical Development & Technology Transfer at Edgewise Therapeutics since May 2024, bringing extensive experience in pharmaceutical development. Prior roles include Senior Director of Pharmaceutical Development & Technology Transfer at TG Therapeutics, Inc., and Project Lead/Senior Scientist at Ferring Pharmaceuticals, where notable work involved implementing QbD principles and developing abuse-deterrent technologies for opioids. Xiaohong's early career featured positions at Purdue Pharma L.P. and Novartis, focusing on formulation and process optimization for both early and late phase projects. Additional experience encompasses management roles in production and quality control at Nanjing Chemical Industrial Company, including the establishment and oversight of production and quality analysis processes. Education was completed at the University of Iowa.